Clinical Trial Update: Planed Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (OPLAR) evaluating organ preservation for low rectal cancer after neoadjuvant chemotherapy; currently recruiting at West China Hospital…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: West China Hospital | Conditions: Rectal Cancer | Phase 3 | Status: RECRUITING